AFINITOR

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug AFINITOR contains one active pharmaceutical ingredient (API):

1 Everolimus
UNII 9HW64Q8G6G - EVEROLIMUS

Everolimus is a selective mTOR (mammalian target of rapamycin) inhibitor. mTOR is a key serine-threonine kinase, the activity of which is known to be upregulated in a number of human cancers.

Read about Everolimus

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AFINITOR Tablet Health Products Regulatory Authority (ZA) MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01EG02 Everolimus L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
Discover more medicines within L01EG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10131F, 10132G, 10133H, 10135K, 11254H, 11257L, 11258M, 11262R, 11267B, 11362B, 11377T, 11591C, 11592D, 11598K, 11599L, 11607X, 11608Y, 2818H, 2819J, 2985D
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 526530901116312, 526530902112310, 526530903119319
Country: CA Health Products and Food Branch Identifier(s): 02339501, 02339528, 02369257, 02425645, 02425653, 02425661
Country: EE Ravimiamet Identifier(s): 1433281, 1433304, 1433315, 1433337, 1471373, 1471384, 1617229, 1617241
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 09538001, 09538004
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 044580, 044591, 548899
Country: FR Base de données publique des médicaments Identifier(s): 62142469, 64201368, 69867865
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 160557, 160562, 241043, 392269, 392271
Country: HK Department of Health Drug Office Identifier(s): 59060, 59061, 61710, 63764, 63765, 63766
Country: IE Health Products Regulatory Authority Identifier(s): 88009, 88304, 88305
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6512, 6513, 6901
Country: JP 医薬品医療機器総合機構 Identifier(s): 4291023F1020, 4291023F2027, 4291023X1026, 4291023X2022
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1050728, 1050730, 1050731, 1050733, 1070279, 1070280, 1070281, 1070282
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 028M2010
Country: NL Z-Index G-Standaard, PRK Identifier(s): 100471, 92568, 92576
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 13653, 13654, 14805
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100211716, 100211722, 100295200
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64504001, W64504002, W64504003, W64505001, W64505002, W64505003
Country: SG Health Sciences Authority Identifier(s): 13749P, 13750P, 14130P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 10283341H, 10283342H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699504011456, 8699504011463, 8699504011470, 8699504011487, 8699504011494, 8699504011500
Country: US FDA, National Drug Code Identifier(s): 0078-0566, 0078-0567, 0078-0594, 0078-0620, 0078-0626, 0078-0627, 0078-0628
Country: ZA Health Products Regulatory Authority Identifier(s): 43/34/1010, 43/34/1133

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.